Correlogic finds way around FDA demands on ovarian test
This article was originally published in Clinica
Executive Summary
Correlogic Systems is reconfiguring its deal with two major laboratories in order to avoid having to file a premarket approval application with the US FDA for its computerised test for ovarian cancer.